Literature DB >> 6227226

Percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris: analysis of early and late results.

J Meyer, H J Schmitz, T Kiesslich, R Erbel, W Krebs, W Schulz, P Bardos, C Minale, B J Messmer, S Effert.   

Abstract

Percutaneous transluminal coronary angioplasty (PTCA) was performed in 50 patients with stable and in 50 patients with unstable angina pectoris, each patient showing an isolated stenosis of more than 80% of the cross-sectional area of a single coronary artery. The technical success rate was 66% in the stable groups (26 of 37 patients [70%] with left anterior descending artery [LAD], 7 of 12 patients [58%] with right coronary artery [RCA]) and 74% in the unstable group (27 of 34 patients [79%] with LAD, 10 of 15 patients [67%] with (RCA). The increase in stenotic area in the unstable group exceeding that in the stable group for LAD stenoses (41.5 +/- 15.1% vs 32.3 +/- 14.5%, p less than 0.03), while in RCA stenoses the results in the stable group were better (45.1 +/- 17.6% vs 32.7 +/- 12.3%, n.s.). One acute vessel occlusion necessitating an emergency bypass operation occurred in each group (2%). The patient in the stable group died (total mortality rate 1%). Sixty-three of the successfully treated patients were routinely restudied 6 months later. According to clinical symptoms, 23% of the stable and 36% of the unstable group were in functional classes III and IV. From the anatomical viewpoint, a restenosis (greater than 85%) was found in 17% of the stable and in 24% of the unstable group. A further spontaneous decrease (greater than 10%) of the vessel obstruction was found in 47% of the stable group and in 12% of the unstable group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1983        PMID: 6227226     DOI: 10.1016/0002-8703(83)90640-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  14 in total

1.  Restenosis after coronary angioplasty: a proposal of new comparative approaches based on quantitative angiography.

Authors:  P W Serruys; D P Foley; P J de Feyter
Journal:  Br Heart J       Date:  1992-10

2.  [How it all started].

Authors:  H J Rupprecht; R Erbel; R Dörr
Journal:  Herz       Date:  2019-02       Impact factor: 1.443

3.  Long-term angiographic follow up, cardiac events, and survival in patients undergoing percutaneous transluminal coronary angioplasty.

Authors:  S M Ernst; T A van der Feltz; E T Bal; L van Bogerijen; E van den Berg; C A Ascoop; H W Plokker
Journal:  Br Heart J       Date:  1987-03

4.  Percutaneous coronary angioplasty: technique, indications, and results.

Authors:  G S Roubin; A R Gruentzig; W J Casarella
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

Review 5.  Drug-eluting stents versus bare-metal stents for acute coronary syndrome.

Authors:  Joshua Feinberg; Emil Eik Nielsen; Janette Greenhalgh; Juliet Hounsome; Naqash J Sethi; Sanam Safi; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2017-08-23

Review 6.  The high-risk unstable angina patient. An approach to treatment.

Authors:  S Kar; Y Wakida; R Nordlander
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

7.  Effect of the increasing use of coronary angioplasty on outcome at one year in patients with unstable angina.

Authors:  S De Servi; P Valentini; L Angoli; E Bramucci; P Barberis; G Mariani; G Specchia
Journal:  Br Heart J       Date:  1995-12

8.  Surgical versus non-surgical management of patients soon after acute myocardial infarction.

Authors:  R W Brower; P Fioretti; M Simoons; M Haalebos; E N Rulf; P G Hugenholtz
Journal:  Br Heart J       Date:  1985-11

Review 9.  Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.

Authors:  J L Cox; A I Gotlieb
Journal:  CMAJ       Date:  1986-05-15       Impact factor: 8.262

10.  Percutaneous transluminal coronary angioplasty in unstable angina: comparison with stable angina.

Authors:  P J Quigley; J Erwin; B J Maurer; M J Walsh; G F Gearty
Journal:  Br Heart J       Date:  1986-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.